<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Pharmaceutical Giant Plotted to Destroy Cancer Drugs to Drive Prices Up 4,000%</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2017/04/17/pharmaceutical-giant-plotted-to-destroy-cancer-drugs-to-drive-prices-up-4000.aspx</link><description>How far is the pharmaceutical industry willing to go to increase its bottom line? The Independent reports that industry giant Aspen Pharmacare purchased five cancer drugs from GlaxoSmithKline (GSK) and used this near-monopoly to hit European buyers with</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>